Hunan Jiudian Pharmaceutical (SZ:300705) Ge Long Hui A P P·2025-10-23 12:26Core Viewpoint - The company plans to invest 50 million yuan of its own funds to establish a joint venture, Hunan Jiutian Shanno Innovative Pharmaceutical Technology Co., Ltd., with two partners, enhancing its capabilities in innovative drug development and related technologies [1] Investment Details - The registered capital of the new company is set at 100 million yuan, with the company holding a 50% stake, Changsha Xiangjiang Shanno holding 30%, and Hainan Jiuzhi Qingyan Technology holding 20% [1] - This investment aims to accelerate the company's reserve and incubation of innovative drugs and technologies [1] Strategic Goals - The initiative is expected to cultivate new products and technologies that align with the company's core business, thereby enhancing its overall competitiveness and sustainable development capabilities [1] - The investment lays a solid foundation for the company's long-term healthy development [1]